0106 QT Deals
BioCentury & Getty Images


Jan. 6 Quick Takes:  Ribometrix gets $25M up front in Genentech RNA deal; plus Dewpoint-Pfizer, Kite-Oxford BioTherapeutics, Illumina-Helix and more

Jan 7, 2021 | 1:03 AM GMT

Ribometrix, Genentech partner for RNA-targeting small molecules
Ribometrix Inc. and the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) are partnering to develop small

Read the full 590 word article

How to gain access

Continue reading with a
two-week free trial.